Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
IPO for SPAC Riverview Acquisition Corp. (RVAC) Opens at $9.90
-
Companies with NDRs 8/06
-
Riverview Acquisition Corp. (RVAC) Prices 25M Unit IPO at $10/unit
-
Riverview Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
-
Great Panther Mining Limited (GPR:CN) (GPL) PT Lowered to Cdn$1.30 at Cantor Fitzgerald, Following Earnings
-
Rio2 Files Final Financing Prospectus
-
CIGNA (CI) PT Lowered to $250 at Cantor Fitzgerald on Disappointing MLR
-
Cigna sees bigger hit to 2021 earnings from pandemic
-
Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update
-
Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update
-
vTv Therapeutics Announces 2021 Second Quarter Financial Results and Provides Corporate Update
-
CVS Health (CVS) PT Raised to $95 at Cantor Fitzgerald
-
Companies with NDRs 8/04
-
Columbia Care (CCHWF) PT Lowered to $5.30 at Cantor Fitzgerald
-
Jushi Holding (JUSHF) PT Lowered to $5.25 at Cantor Fitzgerald
-
Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option
-
Reigo Investments Closes Inaugural $100 Million Securitization of Residential Bridge Loans Powered by AI
-
X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results
-
Form 424B3 Cantor Fitzgerald Income
-
Rani Therapeutics (RANI) IPO Opens Modestly Higher After Weak Pricing
-
Cerner (CERN) PT Raised to $87 at Cantor Fitzgerald Following Earnings
-
Rani Therapeutics Holdings, Inc (RANI) Prices 6.7M Share IPO at $11/sh
-
Rani Therapeutics Announces Pricing of Initial Public Offering
-
UPDATE: Cantor Fitzgerald Starts PolyPid Ltd. (PYPD) at Overweight
-
Orchid Island Capital Announces Second Quarter 2021 Results
-
Coeur d'Alene Mines (CDE) PT Lowered to $9 at Cantor Fitzgerald, Following Earnings
-
Nomad Royalty Company Ltd (NSR:CN) (NSRXF) PT Lowered to Cdn$13.50 at Cantor Fitzgerald, Following Earnings
-
Cantor Fitzgerald Income Trust, Inc. Secures Credit Facility up to $200 Million and Acquires Office Complex in Cupertino, CA
-
Archer and Atlas Crest Announce Strategic Reset of Transaction Terms to Further Align with World-Class Investors and Achieve Long-Term Partnership; Oscar Munoz, Former United Airlines Chairman and CEO
-
Companies with NDRs 7/29
-
Form 8-K Cantor Fitzgerald Income For: Jul 23
-
Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
-
Hutchison China MediTech Ltd. (HCM) PT Raised to $50 at Cantor Fitzgerald
-
Humana (HUM) PT Raised to $508 at Cantor Fitzgerald, Following Earnings
-
Alkermes (ALKS) PT Raised to $25 at Cantor Fitzgerald
-
Teladoc (TDOC) Falls 6% on Growing Losses and Weak Guidance to Prompt a Downgrade to 'Hold' at Deutsche Bank
-
Cybin Inc (CLXPF) Prices 8.8M Share Offering at $3.40/sh
-
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares
-
Amwell Enhances Virtual Care Platform with Two Acquisitions: SilverCloud Health and Conversa Health
-
Teladoc (TDOC) PT Lowered to $185 at Cantor Fitzgerald
-
Companies with NDRs 7/28
-
Cantor Fitzgerald Starts Payoneer (PAYO) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Nyxoah SA (NYXH) at Overweight
-
Cybin (CLXPF) to Offer Common Stock
-
Cybin Announces Overnight Marketed Public Offering of Common Shares
-
HealthStream (HSTM) PT Raised to $28 at Cantor Fitzgerald
-
Cadre Continues Building Commercial Business with Veteran Industry Leaders
-
Peak Sales Potential of Merck's (MRK) Keytruda is Underappreciated - Analyst
-
Companies with NDRs 7/27
-
BiomX Inc. (PHGE) Announces $15 Million Registered Direct Offering of Common Stock, Warrants


